Modeling of signaling pathways in chondrocytes based on phosphoproteomic and cytokine release data

Osteoarthritis and Cartilage

Volumn 22, Issue 3, 2014, Pages 509-518

  Melas, I N ^a,b   Chairakaki, A D ^a,f   Chatzopoulou, E I ^a   Messinis, D E ^a,b   Katopodi, T ^a   Pliaka, V ^b   Samara, S ^e   Mitsos, A ^c   Dailiana, Z ^d   Kollia, P ^e   Alexopoulos, L G ^a  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^b PROTATONCE LTD   (Greece)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d UNIVERSITY OF THESSALY   (Greece)

^e UNIVERSITY OF ATHENS   (Greece)

^f BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Modeling signaling pathways; Pathway optimization; Phosphoproteomic signaling; Signaling pathways in chondrocytes

Indexed keywords

BETA DEFENSIN 1; CXCL1 CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FLAGELLIN; INHIBIN A; INHIBIN BETA A; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHOSPHOPROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; LIGAND; PROTEOME;

ARTICLE; CARTILAGE CELL; CYTOKINE RELEASE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; HYPERTROPHY; PHOSPHOPROTEOMICS; PRIORITY JOURNAL; PROTEOMICS; SIGNAL TRANSDUCTION; STIMULATION; SUPERNATANT; SYSTEM ANALYSIS; BIOLOGICAL MODEL; CHEMISTRY;

CHONDROCYTES; CYTOKINES; HUMANS; LIGANDS; MODELS, BIOLOGICAL; PROTEOME; SIGNAL TRANSDUCTION;

EID: 84896737259     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.01.001     Document Type: Article

References (43)

1. Berenbaum F. Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol 2004, 16(5):616-622.
2. Chakraborti S., Mandal M., Das S., Mandal A., Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003, 253:269-285. 10.1023/A:1026028303196.
3. Baldwin A. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.
4. Marcu K., Otero M., Olivotto E., Borzi R., Goldring M. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets 2010, 11(5):599613.
5. Guilak F., Fermor B., Keefe F., Kraus V., Olson S., Pisetsky D., et al. The role of biomechanics and inflammation in cartilage injury and repair. Clin Orthop Relat Res 2004, 423:17-26.
6. Luyten F.P., Tylzanowski P., Lories R.J. Wnt signaling and osteoarthritis. Bone 2009, 44(4):522-527. 10.1016/j.bone.2008.12.006.
7. Lories R., Luyten F. Bone morphogenetic proteins in destructive and remodeling arthritis. Arthritis Res Ther 2007, 9(2):207. 10.1186/ar2135.
8. Hopkins A.L. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008, 4:682-690.
9. Mobasheri A. Applications of proteomics to osteoarthritis, a musculoskeletal disease characterized by aging. Front physiology 2011, 2:108.
10. Wilson R., Whitelock J.M., Bateman J.F. Proteomics makes progress in cartilage and arthritis research. Matrix Biol 2009, 28(3):121-128. 10.1016/j.matbio.2009.01.004.
11. Shigemizu D., Hu Z., Hung J.-H., Huang C.-L., Wang Y., DeLisi C. Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. PLoS Comput Biol 2012, 8(2):e1002347. 10.1371/journal.pcbi.1002347.
12. Garcia B.A., Platt M.D., Born T.L., Shabanowitz J., Marcus N.A., Hunt D.F. Protein profile of osteoarthritic human articular cartilage using tandem mass spectrometry. Rapid Commun Mass Spectrom 2006, 20(20):2999-3006. 10.1002/rcm.2692.
13. Wu J., Liu W., Bemis A., Wang E., Qiu Y., Morris E.A., et al. Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis. Arthritis Rheum 2007, 56(11):3675-3684. 10.1002/art.22876.
14. Jean-Baptiste V., Frdric L., Gueorgui K., Franois G., Patrick N., Didier M., et al. Establishment of a reliable method for direct proteome characterization of human articular cartilage. Mol Cell Proteomics 2006, 5:1984-1995.
15. Lambrecht S., Verbruggen G., Verdonk P., Elewaut D., Deforce D. Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis. Osteoarthritis and Cartilage 2008, 16(2):163-173. 10.1016/j.joca.2007.06.005.
16. Sinz A., Bantscheff M., Mikkat S., Ringel B., Drynda S., Kekow J., et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoidarthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002, 23(19):3445-3456. 23:19<3445::AID-ELPS3445>3.0.CO;2-J. 10.1002/1522-2683(200210).
17. Liao H., Wu J., Kuhn E., Chin W., Chang B., Jones M.D., et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004, 50(12):3792-3803. 10.1002/art.20720.
18. Catterall J.B., Rowan A.D., Sarsfield S., Saklatvala J., Wait R., Cawston T.E. Development of a novel 2d proteomics approach for the identification of proteins secreted by primary chondrocytes after stimulation by il-1 and oncostatin m. Rheumatology 2006, 45(9):1101-1109. 10.1093/rheumatology/kel060.
19. Haglund L., Bernier S.M., Onnerfjord P., Recklies A.D. Proteomic analysis of the lps-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biol 2008, 27(2):107-118. 10.1016/j.matbio.2007.09.009.
20. Saez-Rodriguez J., Alexopoulos L.G., Stolovitzky G. Setting the standards for signal transduction research. Sci Signal 2011, 4(160). pe10. 10.1126/scisignal.2001844.
21. Alexopoulos L.G., Saez Rodriguez J., Cosgrove B.D., Lauffenburger D.A., Sorger P.K. Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes. Mol Cell Proteomics 2010, 10.1074/mcp.M110.000406.
22. Mitsos A., Melas I.N., Siminelakis P., Chairakaki A.D., Saez-Rodriguez J., Alexopoulos L.G. Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput Biol 2009, 5(12):e1000591. 10.1371/journal.pcbi.1000591.
23. Quinn T., Schmid P., Hunziker E., Grodzinsky A. Proteoglycan deposition around chondrocytes in agarose culture: construction of a physical and biological interface for mechanotransduction in cartilage. Biorheology 2002, 39:27-37.
24. Saez-Rodriguez J., Alexopoulos L., Epperlein J., Samaga R., Lauffenburger D., Klamt S., et al. Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol 2009, 5:331.
25. Melas I.N., Mitsos A., Messinis D., Weiss T., Saez-Rodriguez J., Alexopoulos L.G. Construction of large signaling pathways using an adaptive perturbation approach with phosphoproteomic data. Mol Biosyst 2012, 8:1571-1584. 10.1039/c2mb05482e.
26. Joshi-Tope G., Gillespie M., Vastrik I., D'Eustachio P., Schmidt E., de Bono B., et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res 2005, 33(Suppl 1):D428-D432. 10.1093/nar/gki072.
27. Cerami E.G., Gross B.E., Demir E., Rodchenkov I., Babur, Anwar N., et al. Pathway commons, a web resource for biological pathway data. Nucleic Acids Res 2011, 39(Suppl 1):D685-D690. 10.1093/nar/gkq1039.
28. Kanehisa M., Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28(1):27-30. 10.1093/nar/28.1.27.
29. Gurobi I. Optimization, Gurobi Optimizer Reference Manual 2013.
30. Brooke A., Kendrick D., Meeraus A. GAMS: User's Guide 1988, The Scientiffc Press, Redwood City, California.
31. Saez-Rodriguez J., Goldsipe A., Muhlich J., Alexopoulos L.G., Millard B., Lauffenburger D.A., et al. Flexible informatics for linking experimental data to mathematical models via DataRail. Bioinformatics 2008, 24:840-847. 10.1093/bioinformatics/btn018.
32. Goldring M.B. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis 2012, 4(4):269-285. 10.1177/1759720X12448454.
33. Scanzello C.R., Plaas A., Crow M.K. Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?. Curr Opin Rheumatol 2008, 20(5):565-572. 10.1097/BOR.0b013e32830aba34.
34. Serhan C.N., Brain S.D., Buckley C.D., Gilroy D.W., Haslett C., ONeill L.A.J., et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007, 21(2):325-332. 10.1096/fj.06-7227rev.
35. Dreier R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res Ther 2010, 12(5):216. 10.1186/ar3117.
36. Long F., Schipani E., Asahara H., Kronenberg H., Montminy M. The CREB family of activators is required for endochondral bone development. Development 2001, 128(4):541-550.
37. Murakami S., Balmes G., McKinney S., Zhang Z., Givol D., de Crombrugghe B. Constitutive activation of mek1 in chondrocytes causes stat1-independent achondroplasia-like dwarfism and rescues the fgfr3-deffcient mouse phenotype. Genes Dev 2004, 18(3):290-305. 10.1101/gad.1179104.
38. Merz D., Liu R., Johnson K., Terkeltaub R. Il-8/cxcl8 and growth-related oncogene/cxcl1 induce chondrocyte hypertrophic differentiation. J.Immunol 2003, 171(8):4406-4415.
39. Olivotto E., Vitellozzi R., Fernandez P., Falcieri E., Battistelli M., Burattini S., et al. Chondrocyte hypertrophy and apoptosis induced by GRO require three-dimensional interaction with the extracellular matrix and a co-receptor role of chondroitin sulfate and are associated with the mitochondrial splicing variant of cathepsin B. JCell Physiol 2007, 210(2):417-427. 10.1002/jcp.20864.
40. Medzhitov R., Preston-Hurlburt P., Janeway C.A.J. Ahuman homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 1997, 388(6640):394-397. 10.1038/41131.
41. Kim H.A., Cho M.-L., Choi H.Y., Yoon C.S., Jhun J.Y., Oh H.J., et al. The catabolic pathway mediated by toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 2006, 54(7):2152-2163. 10.1002/art.21951.
42. Su S.-L., Tsai C.-D., Lee C.-H., Salter D., Lee H.-S. Expression and regulation of toll-like receptor 2 by il-1 and fibronectin fragments in human articular chondrocytes. Osteoarthritis and Cartilage 2005, 13(10):879-886. 10.1016/j.joca.2005.04.017.
43. Liu-Bryan R., Pritzker K., Firestein G.S., Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. JImmunol 2005, 174(8):5016-5023.